Skip to main
AAPG
AAPG logo

AAPG Market Capitalization Overview

Market Cap: $3.45B as of Aug 1, 2025

$3.45B
Past Month+$28.72M (0.84%)
As of Aug 1, 2025, AAPG has a market capitalization of $3.45B. Over the past 30 days, its market cap has increased by 1.84%, while in the last 12 months, it has increased by .

Market capitalization represents the total value of Ascentage Pharma Group International as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

AAPG Market Cap Formula = Stock Price * Shares Outstanding

The market cap of AAPG helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

AAPG Market Cap History

DateMarket CapChange
Aug 1, 2025$3.45B+1.84%
Jul 1, 2025$3.39B+54.61%
Jun 2, 2025$2.19B+0.33%
May 1, 2025$2.19B+9.24%
Apr 1, 2025$1.99B+23.41%
Mar 3, 2025$1.62B+3.70%
Feb 3, 2025$1.56B+15.37%
Jan 27, 2025$1.36B

AAPG End of Year Market Cap History

DateMarket CapChange
2025$3.45B

FAQs About Ascentage Pharma Group International (AAPG) Market Cap

As of Aug 1, 2025, the market capitalization of AAPG is $3.45B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Ascentage Pharma Group International’s market capitalization has increased by 0.8400%, changing from $3.42B to $3.45B as of Aug 1, 2025.

In the last 3 months, Ascentage Pharma Group International’s market capitalization has increased by —, changing from – to – as of –.

In the year –, Ascentage Pharma Group International’s market capitalization increased from – in January to – in December, reflecting a — change.

Ascentage Pharma Group International (AAPG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.